Abstract
Prosthetic joint infection (PJI) is an infrequent complication of total hip arthroplasty (THA) or total knee arthroplasty (TKA) but is associated with longer hospital stay, increased hospital cost, and higher morbidity. This chapter critically reviews the literature to form a consensus on the epidemiology of PJI within hip and knee arthroplasty procedures. PJI occurred in 7761 and 16,798 THA and TKA cases in the USA, respectively, in 2010 and is projected to increase to 16,879 and 42,079 cases by 2020. In the USA and internationally, the overall incidence of PJI occurs in 0.7–2.3 % of both THA and TKA procedures. Infection is diagnosed within the first year postoperatively for 60 % of primary surgeries and the vast majority of cases occur within 2 years. Among the reasons for arthroplasty revision, infection is the second most prevalent failure mode in TKA and third for THA, and models project PJI will become the dominant failure mode by 2030. Regardless of revision reason, TKAs that have been previously revised have an increased incidence of infection of 8.3 % and are reported as high as 33 % among arthroplasties previously revised for infection. The most frequently reported risk factors were revealed to be gender, BMI > 50, extended-length procedures, lack of antibiotic bone cement, and comorbidities. Furthermore, treatment for PJI is 2.6–2.8 times more expensive than revision for aseptic loosening and is associated with 1.9–2.2 times longer patient hospital stay.
Keywords
- Total Knee Arthroplasty
- Total Joint Arthroplasty
- Periprosthetic Joint Infection
- Prosthetic Joint Infection
- Revision Total Knee Arthroplasty
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Berger RA, Rosenberg AG, Barden RM, Sheinkop MB, Jacobs JJ, Galante JO. Long-term followup of the Miller-Galante total knee replacement. Clin Orthop Relat Res. 2001;(388):58–67.
Indelli PF, Aglietti P, Buzzi R, Baldini A. The Insall-Burstein II prosthesis: a 5– to 9-year follow-up study in osteoarthritic knees. J Arthroplasty. 2002;17:544–9.
Quintana JM, Arostegui I, Escobar A, Azkarate J, Goenaga JI, Lafuente I. Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med. 2008;168:1576–84.
Rorabeck CH, Murray P. Cost effectiveness of revision total knee replacement. Instr Course Lect. 1997;46:237–40.
Kurtz SM, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. The Journal of bone and joint surgery American volume. 2007;89:In press.
Bourne RB, Maloney WJ, Wright JG. An AOA critical issue. The outcome of the outcomes movement. J Bone Joint Surg Am. 2004;86-A:633–40.
Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am. 2002;84-A:171–7.
Soderman P, Malchau H, Herberts P. Outcome after total hip arthroplasty: Part I. General health evaluation in relation to definition of failure in the Swedish National Total Hip Arthroplasty register. Acta Orthop Scand. 2000;71:354–9.
Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am. 2005;87:1222–8.
Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004;86-A:1909–16.
Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746–51.
Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics. 1995;18:871–3.
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984–91.
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27:61–5e1.
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–5.
Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009;24:84–8.
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:52–6.
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24:105–9.
Dale H, Skramm I, Lower HL, Eriksen HM, Espehaug B, Furnes O, et al. Infection after primary hip arthroplasty. Acta Orthop. 2011;82:646–54.
Jamsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am. 2009;91:38–47.
Jamsen E, Varonen M, Huhtala H, Lehto MU, Lumio J, Konttinen YT, et al. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2010;25:87–92.
Suzuki G, Saito S, Ishii T, Motojima S, Tokuhashi Y, Ryu J. Previous fracture surgery is a major risk factor of infection after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011;19:2040–4.
Kurtz SM, Lau E, Ianuzzi A, Schmier J, Todd L, Isaza J, et al. National Revision Burden for Lumbar Total Disc Replacement in the. Epidemiologic and Economic Perspectives. Spine.: United States; 2010.
Kurtz SM, Medel FJ, MacDonald DW, Parvizi J, Kraay MJ, Rimnac CM. Reasons for revision of first-generation highly cross-linked polyethylenes. J Arthroplasty. 2010;25:67–74.
Graves S, Davidson D, de Steiger R, Tomkins A. Annual Report 2010. Australian National Joint Replacement Registry. Adelaide: Australian Orthopaedic Association; 2010
Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468:45–51.
Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:128–33.
Annual Report The Norwegian Arthroplasty Register. Bergen: Centre of Excellence of Joint Replacements; 2010.
Garellick G, Karrholm J, Rogmark C, Herberts P. Annual Report 2008. Swedish Hip Arthroplasty Register. Göteborg: Department of Orthopaedics, Sahlgrenska University Hospital; 2009.
Lidgien L, Sundberg M, Dahl AW, Robertsson O. Annual Report 2010. The Swedish Knee Arthroplasty Register. Lund: Dept. of Orthopedics, Lund University Hospital; 2010.
Ince A, Rupp J, Frommelt L, Katzer A, Gille J, Lohr JF. Is "aseptic" loosening of the prosthetic cup after total hip replacement due to nonculturable bacterial pathogens in patients with low-grade infection? Clin Infect Dis. 2004;39:1599–603.
Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D, et al. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther. 2007;9:R46.
Kobayashi N, Procop GW, Krebs V, Kobayashi H, Bauer TW. Molecular identification of bacteria from aseptically loose implants. Clin Orthop Relat Res. 2008;466:1716–25.
Darouiche RO, Donovan WH, Del Terzo M, Thornby JI, Rudy DC, Hull RA. Pilot trial of bacterial interference for preventing urinary tract infection. Urology. 2001;58:339–44.
Kubista B, Hartzler RU, Wood CM, Osmon DR, Hanssen AD, Lewallen DG. Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty. Int Orthop. 2011;36:65–71.
Azzam K, McHale K, Austin M, Purtill JJ, Parvizi J. Outcome of a second two-stage reimplantation for periprosthetic knee infection. Clin Orthop Relat Res. 2009;467:1706–14.
Hanssen AD, Osmon DR. Evaluation of a staging system for infected hip arthroplasty. Clin Orthop Relat Res. 2002;403:16–22.
Bozic KJ, Ong K, Lau E, Kurtz SM, Vail TP, Rubash HE, et al. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010;468:2357–62.
Swierstra BA, Vervest AM, Walenkamp GH, Schreurs BW, Spierings PT, Heyligers IC, et al. Dutch guideline on total hip prosthesis. Acta Orthop. 2011;82:567–76.
Jamsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am. 2012;94:e101.
Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am. 2001;83-A:1524–8.
Marchant Jr MH, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91:1621–9.
Bolognesi MP, Marchant Jr MH, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008;23:92–8.
Font-Vizcarra L, Lozano L, Rios J, Forga MT, Soriano A. Preoperative nutritional status and post-operative infection in total knee replacements: A prospective study of 213 patients. Int J Artif Organs. 2011;34:876–81.
Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ. Patient-related Risk Factors for Postoperative Mortality and Periprosthetic Joint Infection in Medicare Patients Undergoing TKA. Clin Orthop Relat Res. 2012;470:130–7.
Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012;94:794–800.
Webb BG, Lichtman DM, Wagner RA. Risk factors in total joint arthroplasty: comparison of infection rates in patients with different socioeconomic backgrounds. Orthopedics. 2008;31:445.
Smabrekke A, Espehaug B, Havelin LI, Furnes O. Operating time and survival of primary total hip replacements: an analysis of 31,745 primary cemented and uncemented total hip replacements from local hospitals reported to the Norwegian Arthroplasty Register 1987–2001. Acta Orthop Scand. 2004;75:524–32.
Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop. 2008;79:335–41.
Kim JM, Mudgal CS, Konopka JF, Jupiter JB. Complications of total elbow arthroplasty. J Am Acad Orthop Surg. 2011;19:328–39.
Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res. 2010;96:124–32.
Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop Relat Res. 1996;331:140–5.
Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89 Suppl 3:144–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jaekel, D.J., Ong, K.L., Lau, E.C., Watson, H.N., Kurtz, S.M. (2014). Epidemiology of Total Hip and Knee Arthroplasty Infection. In: Springer, B., Parvizi, J. (eds) Periprosthetic Joint Infection of the Hip and Knee. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7928-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7928-4_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7927-7
Online ISBN: 978-1-4614-7928-4
eBook Packages: MedicineMedicine (R0)